Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
32 /100
MEDIUM RISK
Score updated Oct 13, 2026

BLFS — BioLife Solutions, Inc. Dilution Risk Tracker

Track BLFS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BLFS — Get alerts when the score changes →

As of October 13, 2026, BioLife Solutions, Inc. (BLFS) has a DilutionWatch DilutionScore of 32/100, rated MEDIUM dilution risk. BioLife Solutions, Inc. has a market capitalization of $1.89B, 48.91M shares outstanding, 190 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for BLFS.
🔔 Track BLFS — Get forecast alerts →

Market Data

Market Cap$1.89B
Shares Outstanding48.91M
Float42.84M
Cash$24.00M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore32/100DilutionWatch score record
Shares Outstanding48.91MVerified float table or market cache
Public Float42.84MVerified float table or market cache
Market Cap$1.89BMarket data cache
Cash Runway48.4 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 8.7% shares (2026Q1 vs prior)
190 institutional holders · 54.49M shares
#1 T. Rowe Price Investment Management, Inc. 6.51M shares
#2 BlackRock, Inc. 6.10M shares
#3 Casdin Capital, LLC 5.96M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.00M
Days to Cover4.3
% of Float9.3%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2024-02-29
xbrl XBRL CONVERTIBLE 2019-03-15
4 INSIDER TRANSACTION 2026-04-10
4 INSIDER TRANSACTION 2026-04-10
4 INSIDER TRANSACTION 2026-04-10
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual BLFS Dilution Snapshot

BioLife Solutions, Inc. (BLFS) has a DilutionScore of 32/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

BLFS's DilutionScore is currently 32/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 24/100 (Low risk).

Period Score Risk Level Duration
Oct 07 – Oct 13, 202632/100MEDIUM7 days
Jul 16 – Oct 06, 202624/100LOW82 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

BLFS shares outstanding have increased 1.5% from 48.15M (Mar 2026) to 48.86M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 25, 202648.86M42.84M▲ 2.88%
May 11, 202648.86M41.64M▲ 0.20%
May 10, 202648.86M41.56M▲ 1.15%
May 03, 202648.86M41.09M▲ 1.12%
Apr 10, 202648.30M40.63M▲ 0.25%
Mar 26, 202648.30M40.53M▲ 0.03%
Mar 12, 202648.15M40.51M▲ 0.24%
Mar 09, 202648.15M40.42M▼ 0.92%
Mar 05, 202648.15M40.79M▲ 0.19%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track BLFS Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment BLFS files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking BLFS — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BLFS
BLFS FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.